ST. PAUL, Minn. —
There will be two public meetings to discuss planning for Minnesota’s new medical marijuana program. The first will be on July 31 and will consist of information about the new duties of a 16-member Task Force on Medical Cannabis Therapeutic Research. The announcement about an early-august session came from the Minnesota Department of Health on Wednesday. It will also be open to the public and their goal is to inform future patients and residents about who potential manufacturers could be and to provide a timetable of the program guidelines. Gov. Mark Dayton and the legislature passed a limited medical marijuana law last session. Although strict it is truly helpful for patients with very debilitating conditions. Patients are allowed to consume their medicine in a liquid, pill or vaporized form of the plant. Qualifying patients would only be those who suffer from eight illnesses including cancer, HIV/AIDS and glaucoma.